Isletopathy in type 2 diabetes mellitus: Implications of islet RAS, islet fibrosis, islet amyloid, remodeling, and oxidative stress

被引:63
|
作者
Hayden, Melvin R. [1 ]
Sowers, James R.
机构
[1] Univ Missouri, Sch Med, Dept Internal Med, Columbia, MO 65211 USA
[2] Univ Missouri, Sch Med, Dept Diabet Endocrinol & Metab, Columbia, MO 65211 USA
[3] Univ Missouri, Sch Med, Dept Pharmacol & Physiol, Columbia, MO 65211 USA
[4] Univ Missouri, Sch Med, Dept Diabet, Columbia, MO 65211 USA
[5] Univ Missouri, Sch Med, Cardiovasc Dis Res Grp, Columbia, MO 65211 USA
关键词
D O I
10.1089/ars.2007.1610
中图分类号
Q5 [生物化学]; Q7 [分子生物学];
学科分类号
071010 ; 081704 ;
摘要
This review focuses primarily on islet structural and functional changes related to an activated islet renin angiotensin system (RAS), islet oxidative-redox imbalance, the concurrence of islet fibrosis (pericapillary, intra- and peri-islet), and islet amyloid deposition ( pericapillary, intra- and peri-islet). The islet-acinar-portal vascular pathway and the emerging important anatomical and functional region, the islet-exocrine interface, are also discussed. Because there is an associated histopathological islet disease in type 2 diabetes mellitus (T2DM), the term isletopathy is discussed in detail. The isletopathy in T2DM is equally important as the other complications of diabetes. Special stains and special lighting ( bright field and crossed polarized light) are utilized, along with light and transmission electron microscopy, in order to better understand islet structural remodeling in T2DM. The importance of an isletopathy in T2DM is supported by numerous remodeling changes within the islet and the islet-exocrine interface. While some of the structural findings are only preliminary observations, additional investigation in this area should lead to the development of new pathophysiological concepts and new therapies regarding the prevention and treatment of T2DM.
引用
收藏
页码:891 / 910
页数:20
相关论文
共 50 条
  • [31] Islet amyloid in type 2 diabetes, and the toxic oligomer hypothesis
    Haataja, Leena
    Gurlo, Tatyana
    Huang, Chang J.
    Butler, Peter C.
    ENDOCRINE REVIEWS, 2008, 29 (03) : 303 - 316
  • [32] Islet amyloid: A critical entity in the pathogenesis of type 2 diabetes
    Hull, RL
    Westermark, GT
    Westermark, P
    Kahn, SE
    JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM, 2004, 89 (08): : 3629 - 3643
  • [33] Islet transplantation in type 1 diabetes mellitus
    Kovacs, KA
    CANADIAN MEDICAL ASSOCIATION JOURNAL, 2001, 164 (02) : 255 - 255
  • [34] ISLET AMYLOID POLYPEPTIDE - THE CAUSE OF TYPE-2 DIABETES
    BRETHERTONWATT, D
    BLOOM, SR
    TRENDS IN ENDOCRINOLOGY AND METABOLISM, 1991, 2 (06): : 203 - 206
  • [35] Diabetes mellitus in cystic fibrosis is characterized by islet amyloidosis
    Couce, M
    OBrien, TD
    Moran, A
    Roche, PC
    Butler, PC
    JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM, 1996, 81 (03): : 1267 - 1272
  • [36] Dual role of interleukin-1β in islet amyloid formation and its β-cell toxicity: Implications for type 2 diabetes and islet transplantation
    Park, Yoo Jin
    Warnock, Garth L.
    Ao, Ziliang
    Safikhan, Nooshin
    Meloche, Mark
    Asadi, Ali
    Kieffer, Timothy J.
    Marzban, Lucy
    DIABETES OBESITY & METABOLISM, 2017, 19 (05): : 682 - 694
  • [37] The role of islet amyloid polypeptide in the counterregulation during and after hypoglycemia in diabetes mellitus type 2
    Bischof, MG
    Ludwig, C
    Stingl, H
    Krebs, M
    Hofer, A
    Nowotny, P
    DIABETES, 1999, 48 : A363 - A363
  • [38] Causative factors for formation of toxic islet amyloid polypeptide oligomer in type 2 diabetes mellitus
    Jeong, Hye Rin
    An, Seong Soo A.
    CLINICAL INTERVENTIONS IN AGING, 2015, 10 : 1873 - 1879
  • [39] Molecular Structure, Membrane Interactions, and Toxicity of the Islet Amyloid Polypeptide in Type 2 Diabetes Mellitus
    Caillon, Lucie
    Hoffmann, Anais R. F.
    Botz, Alexandra
    Khemtemourian, Lucie
    JOURNAL OF DIABETES RESEARCH, 2016, 2016
  • [40] Longitudinal ultrastructure study of islet amyloid in the HIP rat model of type 2 diabetes mellitus
    Hayden, Melvin R.
    Karuparthi, Poorna R.
    Manrique, Camila Margarita
    Lastra, Guido
    Habibi, Javad
    Sowers, James R.
    EXPERIMENTAL BIOLOGY AND MEDICINE, 2007, 232 (06) : 772 - 779